A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma

被引：0
|
作者：
Z. Xu
R. Van Der Jagt
C. Faught
M. Beaulieu Bergeron
机构：
[1] The Ottawa Hospital,Department of Pathology and Laboratory Medicine, Division of Hematopathology
[2] The Ottawa Hospital,Department of Hematology
[3] Children’s Hospital of Ontario,Department of Genetics
[4] University of Ottawa,Department of Pathology and Laboratory Medicine
来源：
Annals of Hematology | 2014年 / 93卷
关键词：
Multiple Myeloma; Bortezomib; Kappa Light Chain; Myeloma Plasma Cell; Normocytic Anemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1251 / 1252
页数：1
相关论文
共 50 条
  • [21] PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma
    Zhang, Xin
    Han, Yang
    Nie, Yu
    Jiang, Yujie
    Sui, Xiaohui
    Ge, Xueling
    Liu, Fang
    Zhang, Ya
    Wang, Xin
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2023, 101 (05): : 595 - 606
  • [22] PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma
    Xin Zhang
    Yang Han
    Yu Nie
    Yujie Jiang
    Xiaohui Sui
    Xueling Ge
    Fang Liu
    Ya Zhang
    Xin Wang
    Journal of Molecular Medicine, 2023, 101 : 595 - 606
  • [23] MicroRNA-138 promotes the progression of multiple myeloma through targeting paired PAX5
    Yan, Xiao
    Wang, Keting
    Shi, Cong
    Xu, Kaihong
    Lai, Binbin
    Yang, Shujun
    Sheng, Lixia
    Zhang, Ping
    Chen, Ying
    Mu, Qitian
    Ouyang, Guifang
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2024, 829
  • [24] IgM Multiple Myeloma Has Unique Attributes Distinguishing It from Other Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma
    King, R. L.
    Howard, M. T.
    Hodnefield, J. M.
    Morice, W. G.
    MODERN PATHOLOGY, 2012, 25 : 347A - 347A
  • [25] Monoallelic expression of Pax5:: A paradigm for the haploinsufficiency of mammalian Pax genes?
    Nutt, SL
    Busslinger, M
    BIOLOGICAL CHEMISTRY, 1999, 380 (06) : 601 - 611
  • [26] IgM Multiple Myeloma Has Unique Attributes Distinguishing It from Other Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma
    King, R. L.
    Howard, M. T.
    Hodnefield, J. M.
    Morice, W. G.
    LABORATORY INVESTIGATION, 2012, 92 : 347A - 347A
  • [27] ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall
    Salyana, Muhammad Atif
    Khan, Shahbaz
    Zhang, Xinmin
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (10) : E395 - E399
  • [28] Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis
    Debus, Jerome
    Lemaire, Pierre
    Alani, Mustafa
    Farhi, Jonathan
    Rose, Johann
    Cussac, Vincent
    Defasque, Sabine
    Denizon, Nathalie
    Ghnaya, Habib
    Besancon-Bergelin, Anne
    Laribi, Kamel
    Pineau-Vincent, Fabienne
    ANNALES DE BIOLOGIE CLINIQUE, 2018, 76 (04) : 451 - 457
  • [29] Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas:: Reassessing the reported association with t(9;14)
    Cook, JR
    Aguilera, NI
    Reshmi-Skarja, S
    Huang, X
    Yu, ZS
    Gollin, SM
    Abbondanzo, SL
    Swerdlow, SH
    HUMAN PATHOLOGY, 2004, 35 (04) : 447 - 454
  • [30] Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers
    Palmisano, WA
    Crume, KP
    Grimes, MJ
    Winters, SA
    Toyota, M
    Esteller, M
    Joste, N
    Baylin, SB
    Belinsky, SA
    CANCER RESEARCH, 2003, 63 (15) : 4620 - 4625
12345